Aptevo Therapeutics Inc. Deferred Tax Liabilities, Gross
Aptevo Therapeutics Inc. (APVO) had Deferred Tax Liabilities, Gross of $800.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-26
- 2025-12-31: Deferred Tax Liabilities, Gross $800.00K.
- 2024-12-31: Deferred Tax Liabilities, Gross $922.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $1.03M.
- 2022-12-31: Deferred Tax Liabilities, Gross $1.12M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $800.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $922.00K 10-K · filed 2026-03-26 |
| 2023-12-31 | $1.03M 10-K · filed 2025-02-14 |
| 2022-12-31 | $1.12M 10-K · filed 2024-03-05 |
| 2021-12-31 | $333.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $632.00K 10-K · filed 2022-03-24 |
| 2019-12-31 | $874.00K 10-K · filed 2021-03-31 |
| 2017-12-31 | $224.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $575.00K 10-K · filed 2018-03-13 |
| 2015-12-31 | $13.84M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |